Importantly, deletion of IL-23R signaling (Il23r−/−Act1−/−) ameliorated hyper Th17 response (including Il21 expression) and the Sjögren’s and SLE-like diseases in the Act1−/− mice. This evidence concerns the gene IL23R and systemic lupus erythematosus.